Accessibility Menu
 
Adicet Bio logo

Adicet Bio

(NASDAQ) ACET

Current Price$6.99
Market Cap$67.08M
Since IPO (2020)-97%
5 Year-97%
1 Year-40%
1 Month-0%

Adicet Bio Financials at a Glance

Market Cap

$67.08M

Revenue (TTM)

$0.00

Net Income (TTM)

$116.80M

EPS (TTM)

$-18.10

P/E Ratio

-0.39

Dividend

$0.00

Beta (Volatility)

1.23 (Average)

Price

$6.99

Volume

64,015.573

Open

$6.81

Previous Close

$6.99

Daily Range

$6.74 - $7.01

52-Week Range

$6.01 - $17.44

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Adicet Bio

Industry

Biotechnology

Employees

102

CEO

Chen Schor, MBA, CPA

Headquarters

Boston, MA 02116, US

ACET Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-68%

Return on Capital

-71%

Return on Assets

-61%

Earnings Yield

-2.56%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$67.08M

Shares Outstanding

9.60M

Volume

64.02K

Short Interest

0.00%

Avg. Volume

149.37K

Financials (TTM)

Gross Profit

$6.38M

Operating Income

$122.11M

EBITDA

$115.73M

Operating Cash Flow

$95.25M

Capital Expenditure

$1.74M

Free Cash Flow

$96.98M

Cash & ST Invst.

$158.53M

Total Debt

$14.74M

Adicet Bio Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$1.47M

N/A

Gross Margin

0.00%

N/A

Market Cap

$67.08M

N/A

Market Cap/Employee

$441.31K

N/A

Employees

152

N/A

Net Income

$30.52M

-6.2%

EBITDA

$34.37M

-26.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$143.79M

-9.6%

Accounts Receivable

$342.00K

N/A

Inventory

$0.00

N/A

Long Term Debt

$11.55M

-18.1%

Short Term Debt

$3.19M

+1.7%

Return on Assets

-60.72%

N/A

Return on Invested Capital

-71.49%

N/A

Free Cash Flow

$20.90M

+13.9%

Operating Cash Flow

$20.91M

+13.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TCRXTScan Therapeutics, Inc.
$1.01-1.94%
GANXGain Therapeutics, Inc.
$1.85-4.64%
HOWLWerewolf Therapeutics, Inc.
$1.01+5.38%
ACRVAcrivon Therapeutics, Inc. Common Stock
$1.52+4.11%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%
NOKNokia
$8.82+0.07%

Questions About ACET

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.